Introduction
As shown in animal and human studies of small groups, there has been somewhat of a consensus about the deleterious effect of metabolic acidosis, a common condition in chronic kidney disease (CKD), by engendering or worsening protein-energy malnutrition, inflammation, and bone diseases leading to a major role in increased mortality from short-term metabolic studies in CKD patients before the initiation of maintenance hemodialysis patients (MHP) [1] [2] [3] [4] [5] .
However, predialysis metabolic acidosis in the majority of epidemiologic studies in MHP have shown an inverse correlation between a mild to moderate degree of hypobicarbonatemia and improved nutritional markers and also better survival than severe hypobicarbonatemia or hyperbicarbonatemia [6] [7] [8] [9] [10] [11] [12] . On the contrary, the most recent largest scale study of 56,385
MHP in all DaVita dialysis clinics across the United
States led to opposite effects of metabolic acidosis in these MHP, depending on the analytical method 13) . In unadjusted data, the lowest mortality was associated with predialysis hypobicarbonatemia ranging from 17 to 23 mEq/L and progressively higher all-cause and cardiovascular mortality rates were associated with predialysis HCO3 levels of equal to or more than 23 mEq/L; whereas, after case-mix and malnutritioninflammation complex syndrome (MICS) multivariate Metabolic acidosis has been considered as one of the reverse epidemiologic factors for the morbidity and mortality in maintenance hemodialysis patients (MHP). Expectedly, in the recent large scale epidemiologic study (The Dialysis Outcome Practice Pattern Study, DOPPS), a mild to moderate degree of predialysis metabolic acidosis has shown better nutritional status and lower relative risk for mortality and hospitalization in MHP. Similarly, another recent study of the largest sample size of MHP of more than 55,000 revealed the lowest unadjusted mortality with mild to moderate degree of predialysis HCO3 levels (17 to 23 mEq/L). However, it was reversed after case-mix and multivariate adjustment, including the malnutrition-inflammation complex syndrome, so that predialysis HCO3 levels of more than 22 mEq/L had a lower death risk. On view of this up-to-date on-going controversy about the optimal acid-base status for MHP, this paper will review the historical and break-through data about the pros and cons of metabolic acidosis published in the clinical human studies of MHP, a special subgroup of chronic kidney disease patients. Based on these results, if possible, we would like to suggest the best practice guideline, particularly, for the optimal predialysis HCO3 level, dialysate HCO3 concentration, and dietary protein intake.
Metabolic acidosis, Hemodialysis
Review article HJ Kim et al : Metabolic Acidosis in Maintenance Hemodialysis Patients adjustment, this association was reversed, so that serum bicarbonate values >22 mEq/L had lower death risk 13) . Therefore, it is an appropriate time to review or revise how to define the adverse effects depending on the degree of metabolic acidosis in MHP in addition to its management, if necessary. . Therefore, the key determinants of metabolic acidosis in MHP were suggested as the amount of protein intake and/or its catabolism, dialysis dose, and specific phosphate binders, rather than the degree of the administration of alkali by dialysis. and increased inflammation 15) . Many CKD patients have progressive muscle wasting and malnutrition despite adequate dialysis, and it is now recognized that one of the major causes of malnutrition in CKD, particularly before the initiation of dialysis, is systemic metabolic acidosis 16) . In fact, the analysis of the Third National Health and Nutrition Examination Survey (NHANES III) showed that low serum bicarbonate was associated with hypoalbuminemia, explaining the high prevalence of hypoalbuminemia in CKD before dialysis 17) . Even in MHP, the correction of metabolic acidosis improved serum albumin levels of MHP 4) . However, it remains disputable whether the adverse nutritional effects and poor clinical outcomes of metabolic acidosis in CKD patients before initiation of hemodialysis can be applicable equally to MHP.
Epidemiologic effects
As shown in Table 1 , the deleterious effect of metabolic acidosis on nutritional status has been noted in some earlier studies for small population of MHP by the studies of Ge et al and Movilli et al. 3, 4) , whereas, the vast majority of recent epidemiologic studies in MHP have revealed a paradoxically inverse relationship between nutritional parameters and metabolic acidosis.
In the analysis of the HEMO study, Uribarri et al reported a significant inverse relationship between serum HCO3 and normalized protein equivalent of nitrogen appearance (nPNA) and showed that MHP with serum HCO3 levels ( 21 mEq/L), compared to those ≤ with serum HCO3 levels ( 25 mEq/L), had a higher ≥ serum creatinine and urea level 6) . Dumler et al reported a higher serum albumin, creatinine, and nPNA in MHP with metabolic acidosis 7) . Inverse association between tCO2 and nPNA Inverse association beteen BMI and acidotic group Inverse association between tCO2 and SUN, P, and uric acid Inverse association between acidemia and nutritional parameters Inverse association between and tCO2 and albumin Inverse association between bicarbonate and nPNA, albumin and BMI Inverse association between bicarbonate and nutritional status and relative risk for mortality & hospitalization (DOPPS) Inverse association between bicarbonate and mortality risk after case-mix and MICS multivariate adjusted analysis Direct association between severe metabolic acidosis and nutritional parameters Direct association between bicarbonateand albumin level MHP, maintenance hemodialysis patients; tCO2, total CO2; nPNA, normalized protein equivalent of nitrogen appearance; BMI, body mass index; SUN, serum urea nitrogen; P, phosphate; MICS, Malnutrition-inflammation complex syndrome ciations between hypobicarbonatemia less than 23 mEq/L and higher death risk after case-mix and MICS multivariate adjustment 13) . Therefore, this study supports that MICS may be the substantial contributor to the counteracting associations between serum bicarbonate levels and mortality in MHD, which could be described as cardiovascular risk-factor paradox or reverse epidemiology in MHD as seen in other cardiovascular risk factors. Given this on-going controversy on epidemiologic studies, it still remains unresolved whether metabolic acidosis is truly harmful. Despite the conflicting results that have been shown in several studies between the association of predialysis acidosis and nutritional parameters such as serum albumin, nPNA, and BMI and those changes following the correction of predialysis metabolic acidosis, it is generally accepted that higher protein intake augments albumin synthesis; whereas, chronic metabolic acidosis has been shown to decrease albumin synthesis 16) . Therefore, a higher protein intake might increase albumin synthesis and this could outweigh the reduction in albumin synthesis due to metabolic acidosis. Furthermore, the subjective global assessment (SGA) correlates better with the outcome of renal failure patients than any other most sophisticated methods of nutritional assessment 20) . Similarly, in MHP, the subjective reported appetite was noted as a key indicator of general health and quality of life (QoL) as well as a main contributor to nutritional status and clinical outcome 21) . Accordingly, the protein-intake of more than 1.2 g/kg/day and highcalorie intake currently recommended by the National Kidney Foundation-K/DOQI Guidelines may be associated with benefits of survival through improved nutritional status, even though it would lead to moderate predialysis metabolic acidosis. Until a uniform guideline of predialysis bicarbonate levels is available by more data to resolve our limited understanding of metabolic acidosis in MHP, its target level could be at or more than 22 mEq/L, but less than 24-25 mEq/L.
Conclusion

